{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:38:21Z","timestamp":1790782701350,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.cgh.2024.07.021","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T19:58:16Z","timestamp":1723492696000},"page":"715-725.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Effects of Glucagon-Like Peptide-1 Receptor Agonists on Upper Gastrointestinal Endoscopy: A Meta-Analysis"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2107-2156","authenticated-orcid":false,"given":"Antonio","family":"Facciorusso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryl","family":"Ramai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jahnvi","family":"Dhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayanta","family":"Samanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Chandan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevas","family":"Gkolfakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano Francesco","family":"Crin\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Maida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Anderloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Boskoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Triantafyllou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Dinis-Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Fuccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Arvanitakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2024.07.021_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076410","article-title":"Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis","volume":"384","author":"Yao","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2024.07.021_bib2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/nyas.14211","article-title":"Incretins in obesity and diabetes","volume":"1461","author":"Chia","year":"2020","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cgh.2024.07.021_bib3","author":"Joshi"},{"key":"10.1016\/j.cgh.2024.07.021_bib4","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.cgh.2023.11.002","article-title":"AGA Rapid Clinical Practice Update on the management of patients taking GLP-1 receptor agonists prior to endoscopy: communication","volume":"22","author":"Hashash","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.07.021_bib5","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.14309\/ajg.0000000000002820","article-title":"Quantified metrics of gastric emptying delay by GLP-1 agonists: a systematic review and meta-analysis with insights for periprocedural management","volume":"119","author":"Hiramoto","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.07.021_bib6","author":"Wells"},{"key":"10.1016\/j.cgh.2024.07.021_bib7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.cgh.2024.07.021_bib8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.cgh.2024.07.021_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.gie.2024.04.2900","article-title":"Effects of glucagon-like peptide-1 receptor agonists on upper endoscopy in diabetic and non-diabetic patients","author":"Nadeem","year":"2024","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cgh.2024.07.021_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinane.2023.111091","article-title":"Relationship between perioperative semaglutide use and residual gastric content: A retrospective analysis of patients undergoing elective upper endoscopy","volume":"87","author":"Silveira","year":"2023","journal-title":"J\u00a0Clin Anesth"},{"key":"10.1016\/j.cgh.2024.07.021_bib11","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/jdi.14005","article-title":"Association of glucagon-like peptide-1 receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy","volume":"14","author":"Kobori","year":"2023","journal-title":"J\u00a0Diabetes Investig"},{"key":"10.1016\/j.cgh.2024.07.021_bib12","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1177\/10600280211055804","article-title":"Impact of glucagon-like peptide-1 receptor agonists (GLP-1RA) on food content during esophagogastroduodenoscopy (EGD)","volume":"56","author":"Stark","year":"2022","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.cgh.2024.07.021_bib13","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.14309\/ajg.0000000000002777","article-title":"Glucagon-like peptide-1 receptor agonists increase solid gastric residue rates on upper\u00a0endoscopy especially in patients with complicated diabetes: a case-control study","volume":"119","author":"Garza","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.07.021_bib14","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s12630-024-02719-z","article-title":"Association of glucagon-like peptide receptor 1 agonist therapy with the presence of gastric contents in fasting patients undergoing endoscopy under anesthesia care: a historical cohort study","volume":"71","author":"Wu","year":"2024","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.cgh.2024.07.021_bib15","doi-asserted-by":"crossref","first-page":"S-1189","DOI":"10.1016\/S0016-5085(24)03194-9","article-title":"Increased risk of residual gastric content in patients on glp-1 agonists undergoing esophagogastroduodenoscopy","volume":"166","author":"Meluban","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.07.021_bib16","doi-asserted-by":"crossref","first-page":"S","DOI":"10.1016\/S0016-5085(24)03207-4","article-title":"Clinical impact of glp-1ra on endoscopy: a retrospective cohort study in endoscopy patients","volume":"166","author":"Karlson","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.07.021_bib17","doi-asserted-by":"crossref","first-page":"S-599","DOI":"10.1016\/S0016-5085(24)01844-4","article-title":"The impact of semaglutide on retained gastric contents during endoscopy","volume":"166","author":"Gu","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.07.021_bib18","doi-asserted-by":"crossref","first-page":"S","DOI":"10.1016\/S0016-5085(24)01939-5","article-title":"Glucagon-like-peptide-1 receptor agonists (GLP-1RA): impact on outpatient upper endoscopy procedure quality","volume":"166","author":"Peng","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.07.021_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.gie.2024.05.012","article-title":"Effects of glucagon-like peptide-1 receptor agonists on gastric mucosal visibility and retained gastric contents during esophagogastroduodenoscopy","author":"Chapman","year":"2024","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cgh.2024.07.021_bib20","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1053\/j.gastro.2024.03.015","article-title":"Increased risk of aspiration pneumonia associated with endoscopic procedures among patients with glucagon-like peptide 1 receptor agonist use","volume":"167","author":"Yeo","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.07.021_bib21","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cgh.2024.04.038","article-title":"Glucagon-like peptide-1 receptor agonists do not increase aspiration during upper endoscopy in patients with diabetes","volume":"23","author":"Barlowe","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.07.021_bib22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11154-014-9289-5","article-title":"Effects of GLP-1 on appetite and weight","volume":"15","author":"Shah","year":"2014","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.cgh.2024.07.021_bib23","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.cgh.2023.11.024","article-title":"Low incidence of\u00a0pulmonary aspiration during upper endoscopy in patients prescribed a glucagon-like peptide 1 receptor agonist","volume":"22","author":"Anazco","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.07.021_bib24","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.cgh.2024.03.013","article-title":"Clinical Outcomes and Safety of Upper Endoscopy While on Glucagon-Like Peptide-1 Receptor Agonists","volume":"23","author":"Firkins","year":"2025","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356524007171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356524007171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:12:18Z","timestamp":1762549938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356524007171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1542356524007171"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2024.07.021","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Glucagon-Like Peptide-1 Receptor Agonists on Upper Gastrointestinal Endoscopy: A Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2024.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}